Filtros : "MIOSITE" "FMRP" Removido: "Heidrich, Vitor" Limpar

Filtros



Limitar por data


  • Fonte: Vaccine. Unidade: FMRP

    Assuntos: IMUNOLOGIA, VACINAS, CRIANÇAS, VARICELA, ARTRITE, MIOSITE

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GROOT, Noortje et al. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment. Vaccine, v. 35, n. 21, p. 2818-2822, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.04.015. Acesso em: 30 set. 2024.
    • APA

      Groot, N., Pileggi, G. C. S., Sandoval, C. B., Grein, I., Berbers, G., Ferriani, V. P. L., et al. (2017). Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment. Vaccine, 35( 21), 2818-2822. doi:10.1016/j.vaccine.2017.04.015
    • NLM

      Groot N, Pileggi GCS, Sandoval CB, Grein I, Berbers G, Ferriani VPL, Wulffraat N, Roock S de. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment [Internet]. Vaccine. 2017 ; 35( 21): 2818-2822.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2017.04.015
    • Vancouver

      Groot N, Pileggi GCS, Sandoval CB, Grein I, Berbers G, Ferriani VPL, Wulffraat N, Roock S de. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment [Internet]. Vaccine. 2017 ; 35( 21): 2818-2822.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2017.04.015
  • Fonte: The Lancet. Unidade: FMRP

    Assuntos: DERMATOPATIAS, MIOSITE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RUPERTO, Nicolino et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, v. 387, n. 10019, p. 671-678, 2016Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(15)01021-1. Acesso em: 30 set. 2024.
    • APA

      Ruperto, N., Pistorio, A., Oliveira, S., Zulian, F., Cuttica, R., Ravelli, A., et al. (2016). Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, 387( 10019), 671-678. doi:10.1016/s0140-6736(15)01021-1
    • NLM

      Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1
    • Vancouver

      Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024